Noramco Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Noramco's estimated annual revenue is currently $46.6M per year.(i)
  • Noramco's estimated revenue per employee is $175,970

Employee Data

  • Noramco has 265 Employees.(i)
  • Noramco grew their employee count by -1% last year.

Noramco's People

NameTitleEmail/Phone
1
VP Government Relations and General CounselReveal Email/Phone
2
ControllerReveal Email/Phone
3
Senior Director Financial Planning & AnalysisReveal Email/Phone
4
Director Sales, Pharmaceutical & Medical OTCReveal Email/Phone
5
Senior Director Maintenance, Engineering, IT & EHSReveal Email/Phone
6
Director Supplier and Program ManagementReveal Email/Phone
7
Associate Manager CMO OversightReveal Email/Phone
8
Program ManagerReveal Email/Phone
9
Project ManagerReveal Email/Phone
10
Senior Supply Chain ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$34M1698%N/AN/A
#2
$8.4M42-28%N/AN/A
#3
$68.7M3426%N/AN/A
#4
$49.4M246-10%N/AN/A
#5
$7.8M3944%N/AN/A
#6
$148.3M7388%N/AN/A
#7
$24.7M12313%N/AN/A
#8
$0.8M814%N/AN/A
#9
$9M457%N/AN/A
#10
$3.8M19-50%N/AN/A
Add Company

What Is Noramco?

Noramco, a subsidiary of healthcare giant Johnson & Johnson, makes active pharmaceutical ingredients used in the medications and medical devices made by Johnson and Johnson subsidiaries (including Ortho-McNeil Pharmaceutical, Janssen, and Ethicon), as well as third parties. The company was founded in 1979 to support the manufacture of Ortho-McNeil's Tylenol with codeine line. It is one of a very few US companies allowed by the DEA to import opium for use in opiate painkillers, such as codeine and morphine. Noramco operates two manufacturing facilities in Athens, Georgia, and Wilmington, Delaware.

keywords:N/A

N/A

Total Funding

265

Number of Employees

$46.6M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Noramco News

2022-04-17 - Global Naltrexone HCL Market 2022 COVID-19 Impact ...

Sanofi; Noramco; Taj Pharmaceuticals; Sun Pharma; Rusan; IVAX; Faran Shimi; Haida Taicheng. Geographically, this report is isolated into a couple of...

2022-04-17 - Substance Abuse Treatment Market Size, Scope And Outlook ...

Allergan PLC, Alkermes, Noramco, Indivior PLC, Teva Pharmaceutical Industries Ltd, Pfizer Mallinckrodt plc, GlaxoSmithKline plc, Pharmaceuticals Ltd,...

2022-04-06 - Settlement talks pause as opioid trial finishes second week

Noramco is a subsidiary of Janssen Pharmaceuticals Inc., which is owned by a defendant in the civil lawsuit, Johnson & Johnson. In the years...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$84.5M2659%N/A
#2
$300M2670%$9M
#3
$79.3M2678%N/A
#4
$89.9M2683%N/A
#5
$81.3M2793%N/A